Opportunity Information: Apply for RFA AT 23 009
The National Institutes of Health (NIH) funding opportunity RFA-AT-23-009 supports the creation of research networks focused on understanding how music-based interventions (MBIs) work at a mechanistic level in two major health areas: pain and Alzheimers disease and Alzheimers disease-related dementias (AD/ADRD). Rather than primarily funding large clinical efficacy trials, this initiative is designed to strengthen the scientific foundation that future clinical studies will rely on. The core idea is to bring together multidisciplinary teams to build shared research frameworks, agree on consistent language and classification systems for MBIs, and generate early mechanistic evidence that can later support stronger, larger NIH grant applications.
A major expectation is that each network will serve as an organizing hub for the field. Networks are expected to develop clear, compelling mechanistic research frameworks that can guide future clinical research on MBIs in pain or AD/ADRD. This includes establishing consistent terminology and a taxonomy (in other words, shared definitions and categories for different types of music-based interventions and their key components). By doing this, the program aims to reduce the fragmentation that often happens when different research groups describe similar interventions in different ways, measure different outcomes, or use incompatible methods, making it hard to compare results across studies.
Another central feature is building and sustaining interdisciplinary collaboration. The networks are expected to actively connect investigators across relevant disciplines, which may include neuroscience, psychology, geriatrics, neurology, pain medicine, rehabilitation, music therapy, cognitive science, bioengineering, and related methodological fields. The FOA encourages applicants to propose activities that make collaboration real and productive, such as meetings, workshops, and conferences; structured research collaborations; and idea exchange through visiting scientist arrangements or training opportunities. These convening and capacity-building activities are not side projects; they are part of how the networks are meant to identify key gaps, align research priorities, and coordinate methods in a way that accelerates progress.
The opportunity also emphasizes pilot projects as a way to move from discussion to data. Networks are expected to initiate pilot studies that test novel mechanistic hypotheses about MBIs and help identify strong mechanistic measures, outcomes, and biomarkers. The intent is to figure out what should be measured (and how) to understand pathways of effect, whether those pathways involve neural circuits, stress physiology, inflammation, cognitive processes, emotional regulation, social connection, or other biological and behavioral mechanisms. The FOA also highlights identifying and incorporating relevant new technologies and methodologies, which can include emerging tools for measurement, analysis, or intervention delivery that could improve rigor, reproducibility, and mechanistic clarity.
Dissemination and outreach are required to ensure the networks have lasting impact beyond the funded period. The FOA expects networks to publish and share their products broadly, including research frameworks, common terminologies and taxonomies, review papers, and other best-practice resources. The goal is to create field-wide reference points that future investigators can use to design stronger studies, select comparable measures, and communicate findings consistently. In practical terms, success is not only judged by what the network learns internally, but also by what it standardizes and contributes back to the wider music-and-health research community.
From an administrative standpoint, this is a cooperative agreement (U24), which generally means NIH will have substantial programmatic involvement compared to a standard research grant. The funding instrument is marked "Clinical Trial Optional," meaning applicants may propose clinical trial components if appropriate, but a clinical trial is not required. The opportunity falls under NIH health research funding categories and is associated with CFDA numbers 93.213 and 93.866. The listed award ceiling is $300,000. The FOA was created on 2022-12-16 and had an original closing date of 2023-01-17.
Eligibility is broad and includes many types of domestic U.S. organizations, such as state, county, city, township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations (other than small businesses); and small businesses. The FOA also explicitly highlights additional eligible applicant types such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), as well as faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions.
There are important limits related to foreign participation. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply, and non-domestic components of U.S. organizations are not eligible to apply. However, foreign components are allowed as defined in the NIH Grants Policy Statement, meaning certain international elements may be included under NIH rules even though the applicant organization must be U.S.-based and the main structure of the work must align with the domestic eligibility constraints.
Overall, this FOA is best understood as an NIH effort to build the shared scientific infrastructure needed for the next generation of rigorous music-based intervention research in pain and AD/ADRD. It prioritizes coordinated mechanistic thinking, common standards, and pilot data generation so that future clinical studies can be more comparable, more biologically and behaviorally grounded, and more competitive for larger-scale NIH funding.Apply for RFA AT 23 009
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Research Networks to Promote Multidisciplinary Mechanistic Studies on Music-Based Interventions for Pain or Alzheimers Disease and Alzheimers Disease Related Dementias (AD/ADRD) (U24 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.213, 93.866.
- This funding opportunity was created on 2022-12-16.
- Applicants must submit their applications by 2023-01-17. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $300,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Health
Next opportunity: Using Just-in-Time Adaptive Interventions to Optimize Established Adolescent Mental Health Treatments (R61/R33 Clinical Trial Required)
Previous opportunity: Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AT 23 009
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AT 23 009) also looked into and applied for these:
| Funding Opportunity |
|---|
| Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional) Apply for PAR 23 063 Funding Number: PAR 23 063 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| Biomedical Research Facilities (C06 Clinical Trial Not Allowed) Apply for PAR 23 045 Funding Number: PAR 23 045 Agency: National Institutes of Health Category: Health Funding Amount: $8,000,000 |
| Autoimmunity Centers of Excellence, Basic Research Program (U19 Clinical Trial Not Allowed) Apply for RFA AI 22 070 Funding Number: RFA AI 22 070 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| Autoimmunity Centers of Excellence, Clinical Research Program (UM1 Clinical Trial Required) Apply for RFA AI 22 071 Funding Number: RFA AI 22 071 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| AHRQ and PCORI Learning Health System Embedded Scientist Training and Research Centers (P30) Apply for RFA HS 23 001 Funding Number: RFA HS 23 001 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Pilot Studies for the Spectrum of Alzheimers Disease/Alzheimers Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional) Apply for PAR 23 083 Funding Number: PAR 23 083 Agency: National Institutes of Health Category: Health Funding Amount: $325,000 |
| Early and Late Stage Clinical Trials for the Spectrum of Alzheimers Disease/Alzheimers Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional) Apply for PAR 23 081 Funding Number: PAR 23 081 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Understanding the Supply of Professional Dementia Care Providers and Their Decisions (U54 Clinical Trial Not Allowed) Apply for RFA AG 24 024 Funding Number: RFA AG 24 024 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: Brain Tissue Resource Center for Alcohol Research (R28 Clinical Trial Not Allowed) Apply for PAR 23 068 Funding Number: PAR 23 068 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAMS Resource-based Centers for Bone, Muscle and Orthopaedic Research (P30 - Clinical Trial Not Allowed) Apply for RFA AR 24 002 Funding Number: RFA AR 24 002 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| NIAMS Skin Biology and Diseases Resource-based Centers (P30 - Clinical Trial Not Allowed) Apply for RFA AR 24 001 Funding Number: RFA AR 24 001 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R01 Clinical Trial Optional) Apply for RFA MH 23 115 Funding Number: RFA MH 23 115 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R21 Clinical Trial Optional) Apply for RFA MH 23 116 Funding Number: RFA MH 23 116 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| HEAL Commercialization Readiness Pilot (CRP) Program: Embedded Entrepreneurs for Small Businesses in Pain Management (SB1 Clinical Trial Not Allowed) Apply for PAR 23 069 Funding Number: PAR 23 069 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Research Centers in Minority Institutions (RCMI) (U54 Clinical Trial Optional) Apply for RFA MD 23 001 Funding Number: RFA MD 23 001 Agency: National Institutes of Health Category: Health Funding Amount: $3,500,000 |
| Laboratories to Optimize Digital Health (R01 Clinical Trial Required) Apply for PAR 23 096 Funding Number: PAR 23 096 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Tools and resources to understand the vascular pathophysiology of in vivo neuroimaging findings in TBI-related dementia and/or VCID (U24 - Clinical Trials Not Allowed) Apply for RFA NS 23 002 Funding Number: RFA NS 23 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Effectiveness of Implementing Sustainable Evidence-Based Mental Health Practices in Low-Resource Settings to Achieve Mental Health Equity for Traditionally Underserved Populations (R01 Clinical Trial Optional) Apply for PAR 23 092 Funding Number: PAR 23 092 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Initiation of a Mental Health Family Navigator Model to Promote Early Access, Engagement and Coordination of Needed Mental Health Services for Children and Adolescents (R01 Clinical Trial Required) Apply for PAR 23 094 Funding Number: PAR 23 094 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional) Apply for PAR 23 097 Funding Number: PAR 23 097 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AT 23 009", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
